The Variability of HR+ Breast Cancer

Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016

Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.

September 2, 2015

Changing the Way Takeda Oncology Develops Cancer Medicines

Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.